Astellas

Sing music microphone

Melodia sings $275M song for Alivexis' cathepsin C inhibitor

Switzerland’s Melodia Therapeutics has signed a $275 million biobucks deal to get its hands on Alivexis’ preclinical cathepsin C inhibitor.

James Waldron Jun 21, 2024 5:07am

Bayer Whippany

Bayer posts pivotal data on rival to Astellas in menopause space

May 17, 2024 6:45am

gold rocks gold rush bonanza mining precious metals

Bayer to take menopause drug to regulators after 3rd ph. 3 win

Mar 19, 2024 7:17am

Cork bottle wine

Astellas puts the cork back in $350M Xork deal with Cartesian

Mar 14, 2024 10:41am

Bayer

Bayer hits hot flash phase 3 goals to stay on Astellas’ heels

Jan 8, 2024 10:16am

graphic image of different colored hands shaking

Phenomic inks 2nd deal in 2 days, Shape adds to Roche pact

Nov 30, 2023 10:14am